The size of the U.S. wave has given regulators and scientists an opportunity to better assess vaccine efficacy in children aged 6 months to 4 years old, said Dr. Scott Gottlieb, who sits on the board of the vaccine maker Pfizer.
from NYT > Top Stories https://ift.tt/A1LU6C4 Read about Implantation bleeding quiz https://urlzs.com/fZw6K Chlamydia in men https://urlzs.com/W3NV1 https://ift.tt/cGJLnqz https://youtu.be/QFwQ6JvyPa8
No comments:
Post a Comment